SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Anthony @ Equity Investigations, Dear Anthony,

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jane4IceCream who wrote (40513)7/8/1999 10:25:00 AM
From: cirrus  Read Replies (2) of 122087
 
Jane:

A few weeks ago you suggested I take a look at IMCL. Well I did, and I picked up a bunch.

However, the irony, if you can call it that, is that c225 is in P3 for the exact same type head and neck cancer a relative of mine is battling. He went through radiation and is now facing surgery. The doctors are optimistic as to the outcome.

I sent him the info on c225. He understands that one cannot entertain false hopes, and much has to happen before c225 is available for general use - and much can go wrong. However, it has given him a basis to believe that should he make it through the next two years or so, a very reasonable assumption, effective medical treatment other than the horrors of more radiation and surgery might be available should the cancer recur.

Sometimes hope is the best one can offer. Jane, thank you.



Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext